Infectious Disease

Required Rotations

• Orientation/Microbiology Lab (4 weeks)
• Antimicrobial Stewardship I (4 weeks)
• General Adult Infectious Diseases I (8 weeks)
• Antimicrobial Stewardship II (4 weeks)
• Pediatric Infectious Diseases (4 weeks)
• Introduction to Clinical Outcomes Research (4 weeks)
• Clinical Outcomes Research (4 weeks)
• Antimicrobial Stewardship II (4 weeks)
• Immunocompromised Host, Adult Infectious Diseases (8 weeks)

Elective Rotations 

• Critical Care (4 weeks)
• Adult hematology/oncology (2-3 weeks)
• Bone marrow transplant (2-3 weeks)

Staffing 

• Longitudinal weekend staffing every 6 weeks
• Includes coverage of 1 institution recognized holiday 

Research

• Fellow will be expected to submit an IRB, collect data, and develop and complete a research project suitable for poster presentation at an Infectious Diseases conference.

Teaching 

• Participate in community service events with the student professional organizations.
• Co-precept pharmacy students, PGY1 and PGY2 residents.
• Lead one designated Infectious Diseases team-based learning lecture to LLU School of Pharmacy students.
• Prepare and present a continuing education presentation to LLU faculty, staff, and affiliates. 

Required Rotations 

• Clinical Microbiology Laboratory Research (8 weeks) 
• Clinical Outcomes Research (32 weeks; over 8 months, 2-3 week blocks)
• Antimicrobial Stewardship III (4 weeks)
• Antimicrobial Stewardship IV (4 weeks)

Electives (32 weeks; over 8 months, 1-2 week blocks)

• Adult hematology/oncology
• Bone marrow transplant
• General Adult Infectious Diseases 
• Informatics
• Immunocompromised Host, Adult Infectious Diseases
• Microbiology Lab
• Pediatric Infectious Diseases

Staffing 

• Longitudinal weekend staffing every 6 weeks
• Includes coverage of 1 institution recognized holiday

Research

• Clinical outcomes research.
• Infectious Disease Pharmacokinetics/ Pharmacodynamics (PK/PD) Research.
• Fellows will be expected to publish at least 3 first author original research manuscripts by the completion of the fellowship.

Teaching 

• Participate in community service events with the student professional organizations.
• Give two hours of didactic lecture in the infectious diseases module.
• Prepare and present a continuing education presentation to LLU faculty, staff, and affiliates. 

• $60,000 annually, paid bi-weekly
• Full Medical and Dental plans
• Up to 10 days of annual paid vacation 
• Up to 10 days of annual professional leave (conferences, interviews, licensure exam)
• Conference budget of up to $2,500
• Del Webb library and online access to database information and journal articles
• Personal computer with Word, Excel, Power Point programs and drug information retrieval within a shared office for all residents equipped with a workspace and telephone
• Free copying/printing
• Full use of the Drayson Center
• Free tuition for LLU courses is available for up to 8 units per year with a passing grade of “C” or better

Requirements

1. Graduate of an Accreditation Council for Pharmacy Education (ACPE)-accredited school of pharmacy
2. Completion of an ASHP-accredited PGY-1 pharmacy residency
3. Active California Intern License by October 6, 2025, and must be eligible for full pharmacist licensure by December 1, 2025
4. Accepting applications until April 7, 2025

Recruitment events 2024-2025

• TBA

Fellow Led Peer-Reviewed Publications

Tan K, Hino G Jr, Zhou AY, Al-Fayiz H, Rodriguez S, Abdul-Mutakabbir JC. Identifying the potential impact of a multidisciplinary outpatient antimicrobial therapy program in an area of high social vulnerability. Ther Adv Infect Dis. 2023 Aug 24;10:20499361231194257.

Grant VC, Abdul-Mutakabbir JC, Tan K. Clinical Outcomes Associated with FDA Approved Molecular Rapid Diagnostic Tests in Patients with Candidemia. MAD-ID 2021 Winter Issue.

Grant VC, Abdul-Mutakabbir JC, Tan K. Strengths and Limitations of T2Candida Implementation from an Antimicrobial Stewardship Perspective. Contagion. October 2021 Volume 6, Issue 5

Grant VC, Zhou AY, Tan K, Abdul-Mutakabbir JC. Racial disparities among candidemic patients at a Southern California teaching hospital. Infect Control Hosp Epidemiol. 2023 Nov;44(11):1866-1869.

Grant VC, Nguyen K, Rodriguez S, Zhou AY, Abdul-Mutakabbir JC, Tan K. Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis. Trop Med Infect Dis. 2022;7(2):23. Published 2022 Feb 3. doi:10.3390/tropicalmed7020023

McLeod CC, Tan K, Kebriaei R, Abdul-Mutakabbir JC. Clinical Appraisal Of Cefiderocol in the Treatment of Non-Fermenting Gram-Negative Bacilli. Curr Infect Dis Rep 25, 45–60 (2023). https://doi.org/10.1007/s11908-023-00800-0

McLeod CC, Al-Fayiz H, Rodriguez S, Tan K, Abdul-Mutakabbir JC. Examining racial and social vulnerability disparities in the outpatient treatment of uncomplicated cystitis at a Southern California Academic Hospital. Antimicrob Steward Healthc Epidemiol. 2023 Nov 29;3(1):e214. doi: 10.1017/ash.2023.469.

Shremo Msdi A, Abdul-Mutakabbir JC, Tan KK. Characterizing Day 1 Area Under the Curve Following Vancomycin Loading Dose Administration in Adult Hospitalized Patients Using Non-Trapezoidal Linear Pharmacokinetic Equations: A Retrospective Observational Study. Infect Dis Ther. 2024 Jun 26. doi: 10.1007/s40121-024-01004-2.

Other Peer-Reviewed Publications 

Lee JM, Zhou AY, Ortiz-Gratacos NM, Al Isso A, Tan K, Abdul-Mutakabbir JC. Examining the impact of racial disparities on Clostridioides difficile infection outcomes at a Southern California academic teaching hospital. Infect Control Hosp Epidemiol. 2023 May 4;44(11):1-5.

Abdul-Mutakabbir J, Tan K. Chapter 10 - COVID-19: secondary and superimposed bacterial infections. COVID-19 Viral Sepsis, Academic Press, 2023, Pages 183-201, ISBN 9780323918121, https://doi.org/10.1016/B978-0-323-91812-1.00009-3.

Abdul-Mutakabbir JC, Opoku NS, Tan K, Jorth P, Nizet V, Fletcher HM, Kaye KS, Rybak MJ. Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in Acinetobacter baumannii. Antibiotics (Basel). 2024 Jan 4;13(1):47.

Abdul-Mutakabbir JC, Tan K, Johnson CL, McGrath CL, Zerr DM, Marcelin JR. Prioritizing Equity in Antimicrobial Stewardship Efforts (EASE): a framework for infectious diseases clinicians. Antimicrob Steward Healthc Epidemiol. 2024 May 3;4(1):e74. doi: 10.1017/ash.2024.69.

Fellow Led Research Posters

Hino G Jr, Nguyen K, Grant VC, Rodriguez S, Zhou A, Abdul-Mutakabbir JC, Tan K. The Utility of Verigene Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) and Concordance with MicroScan Conventional Panels at a Large Academic Medical Center. Fellow Virtual Poster, Research-In-Progress. ACCP Annual Meeting 2021. Virtual Conference.

Hino G Jr, Abdul-Mutakabbir JC, Hamada N, Zhou A, Tan K. Identifying the Role for a Pharmacist on an Outpatient Parenteral Antimicrobial Therapy (OPAT) Team in an Academic Teaching Hospital. ID Week 2021, Virtual Conference. 

Nguyen K, Hino G Jr, Grant VC, Rodriguez S, Zhou A, Tan K, Abdul-Mutakabbir JC. Evaluation of VERIGENE Gram-Negative Blood Culture Test Performance at a Large Academic Medical Center. Student Virtual Poster, Research-In-Progress. ACCP Annual Meeting 2021. Virtual Conference.

Nguyen K, Hino G Jr, Zhou A, Tan K, Abdul-Mutakabbir JC. Concordance Between Microscan and the Verigene Gram-Negative Panel in Identifying Ceftriaxone-resistant Enterobacterales at a Large Academic Medical Center. Student Virtual Poster. ASHP Annual Meeting 2021.

Grant VC, Rodriguez S, Hino G, Nguyen K, Zhou A, Abdul-Mutakabbir JC, Tan K. Evaluating the role of T2Candida utilization at a large academic medical center. Fellow Virtual Poster. ASHP Annual Meeting 2021.

Grant VC, Rodriguez S, Hino G, Nguyen K, Zhou A, Abdul-Mutakabbir JC, Tan K. Potential utility of T2Candida at a large academic medical center. Fellow Virtual Poster, Research-In-Progress. ACCP Annual Meeting 2021. Virtual Conference.

Grant V, Rodriguez S, Hino G, Nguyen K, Zhou A, Abdul-Mutakabbir JC, Tan K. Potential utility of T2Candida at a large academic medical center. Fellow Virtual Poster, Research-In-Progress. ACCP Annual Meeting 2021. Virtual Conference.

Rodriguez S, Grant V, Nguyen K, Hino G, Zhou A, Tan K, Abdul-Mutakabbir JC. Identifying risk factors associated with candidemia at a large academic medical center. Student Virtual Poster. ASHP Annual Meeting 2021.

Rodriguez S, Grant V, Nguyen K, Hino G, Zhou A, Tan K, Abdul-Mutakabbir JC. Identifying risk factors associated with candidemia at a large academic medical center. Student Virtual Poster, Research-In-Progress. ACCP Annual Meeting 2021. Virtual Conference.

Grant V, Nguyen K, Rodriguez S, Zhou A, Abdul-Mutakabbir JC, Tan K. Safety and clinical outcomes associated with high-dose micafungin for proven invasive fungal disease. Virtual Poster. ECCMID 2022. Virtual conference.

Grant VC, Zhou AY, Abdul-Mutakabbir JC, Tan K. Characterizing obese patients treated with standard doses of micafungin for proven invasive candidiasis. ACCP Annual Meeting 2022, San Francisco, CA.

Grant VC, Zhou AY, Abdul-Mutakabbir JC, Tan K. Racial Differences in Candidemic Patients at a Southern California Teaching Hospital. ID Week 2022, Washington DC. 

McLeod C, Nguyen K, Zhou A, Abdul-Mutakabbir JC, Tan K. Characterizing Resistance Mechanisms and Antimicrobial Susceptibility Profiles of Acinetobacter spp. Isolates Identified by Rapid Diagnostic Testing at an Academic Medical Center. Fellow Virtual Poster. ASHP Annual Meeting 2021.

McLeod C, Tan K, Abdul-Mutakabbir JC. Characterizing the Clinical Outcomes of Patients with Positive Blood Cultures Not Identified by Rapid Diagnostics. IDWeek 2023, Boston, MA.

McLeod C, Al-Fayiz H, Rodriguez S, Zhou AY, Tan K, Abdul-Mutakabbir JC. Racial differences in the treatment of urinary tract infections in the outpatient setting. Virtual Poster. ECCMID Conference 2023.

Nguyen K, McLeod C, Tan K, Abdul-Mutakabbir JC. Examining the Racial Differences in Polymicrobial Bacteremia Infections in an Area of Varying Social Vulnerability. IDWeek 2023, Boston, MA.

Rodriguez S, Al-Fayiz H, McLeod C, Tan K, Abdul-Mutakabbir JC. Racial Disparities in Cystitis Management at a Large Academic Emergency Department and Urgent Care Setting. ACCP Annual Meeting 2022, San Francisco, CA.

McLeod C, Al-Fayiz H, Rodriguez S, Zhou AY, Abdul-Mutakabbir JC, Tan K.   Characterization of Trends in the Microbiology and Treatment of Urinary Tract Infections in the Emergency Department. ACCP Annual Meeting 2022, San Francisco, CA.

Tan K, McLeod C, Nguyen K, Zhou A, Abdul-Mutakabbir JC. Characterizing the Anaerobic Organisms Unidentified by the Verigene Blood Culture Nucleic Acid Test at an Academic Medical Center. Virtual Poster. ECCMID 2022. Virtual conference.

Shremo Msdi A, Abdul-Mutakabbir JC, Tan K. Characterizing Day 1 Area Under the Curve Following Vancomycin Loading Dose Administration in Adult Hospitalized Patients Using Non-Trapezoidal Linear Pharmacokinetic Equations: A Retrospective Observational Study. ACCP Annual Meeting 2023. Dallas, TX.

Shremo Msdi A, Abdul-Mutakabbir JC, Tan K. Comparison of Non-trapezoidal and Trapezoidal Pharmacokinetic Equations to Calculate Vancomycin Area Under the Curve within 24 Hours of Therapy in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia. IDWeek 2024, Los Angeles, CA. 

Other Research Posters/Oral Abstracts

Opoku NS, Marasigan EL, Torres J, Tan K, Abdul-Mutakabbir JC. In-Vitro Antibacterial Activity of SPR206, a Novel Polymyxin Derivative, compared to Colistin alone and in combination against Multidrug- resistant Acinetobacter baumannii. ACCP Annual Meeting 2022, San Francisco, CA.  

Zhou AY, Lee JM, Ortiz-Gratacos NM, Student P, Isso AA, Tan K, Abdul-Mutakabbir JC. Impact of Racial Disparities on Clostridioides difficile Infection (CDI) Outcomes at a Southern California Academic Teaching Hospital. IDWeek 2022, Washington DC.

Afable T, Zhou AY, Tan K, Abdul-Mutakabbir JC. Utilization of the CDC/ATSDR SVI Interactive Map in Assessing Initial Clostridioides difficile Infection Outcomes. ACCP Annual Meeting 2023, Dallas, TX.  

SaKyi Opok N, Marasigan L, Torres J, Tan K, Abdul-Mutakabbir JC. In-vitro Antibacterial Activity of SPR206 against Carbapenem-resistant Acinetobacter baumannii. Poster Presentation. ASHP Annual Meeting 2023.

Afable T, Zhou AY, Tan K, Abdul-Mutakabbir JC. Utilizing the CDC SVI Tool as a Surrogate of Social Determinants of Health Among Adults with Initial Clostridioides difficile Infection. Oral abstract. IDWeek 2024, Los Angeles, CA.